A mysterious heart ailment almost killed Kevin Moore. It took a Vanderbilt team to pull him through.

“I think Kevin’s story really shows that if you can get people through that early sick period with the best management, the patient can do very well.”

From left, Jennifer Pietenpol, PhD, VUMC Executive Vice President for Research, Vanderbilt Prize in Biomedical Science recipient Christine Seidman, MD, Vanderbilt Prize Scholar Megan Rasmussen and Lawrence Marnett, PhD, Dean of Basic Sciences, School of Medicine.

Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.

Cardiac dysfunction in DMD

The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

Children’s Hospital recognized for cardiomyopathy care quality

Monroe Carell Jr. Children’s Hospital at Vanderbilt has been named an accredited center of care by the Children’s Cardiomyopathy Foundation (CCF), a national nonprofit committed to improving the health outcomes and quality of life for children with cardiomyopathy.

Patient undergoes surgical first to treat his arrhythmia

The state of Michael Stanbery’s health was shocking.

Rare condition leads to new heart, second chance for girl

Michelle Browning never imagined her nursing skills would save the life of her youngest child. But without her natural instinct to begin CPR her daughter, 9-year-old Lexi, may not have survived after her heart suddenly stopped.